Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 12 (NDUFA12) is a nuclear-encoded accessory subunit of mitochondrial Complex I, the largest enzyme complex of the mitochondrial electron transport chain[1][2][3]. While not part of the catalytic core, NDUFA12 is essential for the assembly, stability, and function of Complex I, enabling the transfer of electrons from NADH to ubiquinone and proton translocation across the mitochondrial inner membrane[1][2][3]. Alterations or mutations in NDUFA12 are associated with mitochondrial complex I deficiency, leading to clinical phenotypes including Leigh syndrome, a severe neurodegenerative disorder[1][2][3]. NDUFA12 loss disrupts mitochondrial structure and function, illustrating its crucial role in energy metabolism and cellular homeostasis. Key points are based on authoritative gene function summaries and clinical genetics resources[1][2][3]. - [1]: NDUFA12 is not an enzymatic subunit but is required for Complex I stability and assembly. - [2]: Mutations in NDUFA12 can result in isolated Complex I deficiency, presenting as Leigh syndrome and other mitochondrial encephalopathies. - [3]: It plays no direct catalytic role but is indispensable for Complex I biogenesis and electron transport chain integrity. No drugs are currently known to directly target NDUFA12, but defects can act as biomarkers for diagnosis of mitochondrial diseases[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 12 (NDUFA12).